3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Prostatic Neoplasms, Castration-Resistant
2
Seizures
1
Prostate Cancer Metastatic
1
Primary Dysautonomias
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Kidney Diseases
1
Hypertension
1
Dementia
1
Cognitive Dysfunction
1
Interventions
Osilodrostat
2
enzalutamide
1
clevidipine
1
bicalutamide
1
aliskiren
1
Tumor Necrosis Factors
1
Sodium Chloride
1
Receptors, Androgen
1
Leuprolide
1
Infliximab
1
Goserelin
1
Flutamide
1
Amlodipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Hypertension
×
enzalutamide
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled